Cited by 899Cancer, Hypoxia, and MetabolismCancer Immunotherapy and BiomarkersImmune cells in cancer

The DOI matches its Crossref record; 229 of the 229 references it cites were found in a registry or an index.

Metabolism of immune cells in cancer

Open access

Leone, Robert D., Powell, Jonathan D.·2020·Nature Reviews Cancer

DOI 10.1038/s41568-020-0273-yPMC PMC8041116

Open this paper in CoChat — free account

Abstract

Through the successes of checkpoint blockade and adoptive cellular therapy, immunotherapy has become an established treatment modality for cancer. Cellular metabolism has emerged as a critical determinant of the viability and function of both cancer cells and immune cells. In order to sustain prodigious anabolic needs, tumours employ a specialized metabolism that differs from untransformed somatic cells. This metabolism leads to a tumour microenvironment that is commonly acidic, hypoxic and/or depleted of critical nutrients required by immune cells. In this context, tumour metabolism itself is a checkpoint that can limit immune-mediated tumour destruction. Because our understanding of immune cell metabolism and cancer metabolism has grown significantly in the past decade, we are on the cusp of being able to unravel the interaction of cancer cell metabolism and immune metabolism in therapeutically meaningful ways. Although there are metabolic processes that are seemingly fundamental to both cancer and responding immune cells, metabolic heterogeneity and plasticity may serve to distinguish the two. As such, understanding the differential metabolic requirements of the diverse cells that comprise an immune response to cancer offers an opportunity to selectively regulate immune cell function. Such a nuanced evaluation of cancer and immune metabolism can uncover metabolic vulnerabilities and therapeutic windows upon which to intervene for enhanced immunotherapy. This Review discusses our current understanding of adaptive and innate immune cell metabolism in the context of the tumour microenvironment, providing insight into the interaction of cancer cell metabolism and immune metabolism, as well as the potential for leveraging metabolic vulnerabilities to enhance the antitumour immune response.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41568-020-0273-y

Cites

229 of 229 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

RETRACTED: mTORC1-Induced HK1-Dependent Glycolysis Regulates NLRP3 Inflammasome Activation
Moon, J.-S., Hisata, S., Park, M. A., DeNicola, G. M., Ryter, S. W., Nakahira, K., & Choi, A. M. K. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.05.046 · Cited by 379
Retracted
5-Fluorouracil: mechanisms of action and clinical strategies
Longley, D. B., Harkin, D. P., & Johnston, P. G. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1074 · Cited by 5,332
The M1 and M2 paradigm of macrophage activation: Time for reassessment
Martinez, F. O., & Gordon, S. (2014) · F1000Prime Reports · doi:10.12703/p6-13 · Cited by 4,689
Succinate is an inflammatory signal that induces IL-1β through HIF-1α
Tannahill, G. M., Curtis, A. M., Adamik, J., Palsson-McDermott, E. M., McGettrick, A. F., Goel, G., Frezza, C., Bernard, N. J., Kelly, B., Foley, N. H., et al. (2013) · Nature · doi:10.1038/nature11986 · Cited by 4,176
Modulation of oxidative stress as an anticancer strategy
Gorrini, C., Harris, I. S., & Mak, T. W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4002 · Cited by 3,579
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Chang, C.-H., Qiu, J., O’Sullivan, D., Buck, M. D., Noguchi, T., Curtis, J. D., Chen, Q., Gindin, M., Gubin, M. M., van der Windt, G. J. W., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.016 · Cited by 3,331
Functional Polarization of Tumour-Associated Macrophages by Tumour-Derived Lactic Acid
Colegio, O. R., Chu, N.-Q., Szabo, A. L., Chu, T., Rhebergen, A. M., Jairam, V., Cyrus, N., Brokowski, C. E., Eisenbarth, S. C., Phillips, G. M., et al. (2014) · Nature · doi:10.1038/nature13490 · Cited by 3,046
Mitochondrial TCA cycle metabolites control physiology and disease
Martínez-Reyes, I., & Chandel, N. S. (2020) · Nature Communications · doi:10.1038/s41467-019-13668-3 · Cited by 2,813
Physiological Roles of Mitochondrial Reactive Oxygen Species
Sena, L. A., & Chandel, N. S. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.09.025 · Cited by 2,632
Prevention of Allogeneic Fetal Rejection by Tryptophan Catabolism
Munn, D. H., Zhou, M., Attwood, J. T., Bondarev, I. E., Conway, S. J., Marshall, B., Brown, C. C., & Mellor, A. L. (1998) · Science · doi:10.1126/science.281.5380.1191 · Cited by 2,589

Show all 228 references

Sorted by citations

Items 801–899 of 899

Additional file 2 of Identification of a novel lipid metabolism-related gene signature within the tumour immune microenvironment for breast cancer
Chang, X., & Xing, P. (2022) · Figshare · doi:10.6084/m9.figshare.19766415
Additional file 4 of Clinical significance and oncogenic function of NR1H4 in clear cell renal cell carcinoma
Huang, S., Hou, Y., Hu, M., Hu, J., & Liu, X. (2022) · Figshare · doi:10.6084/m9.figshare.21171518
Additional file 2 of Immune-Related Long Non-coding RNA Constructs a Prognostic Signature of Ovarian Cancer
Sun, X., Li, S., Lv, X., Yan, Y., Wei, M., He, M., & Wang, X. (2021) · Figshare · doi:10.6084/m9.figshare.17205003
Additional file 3 of High tumor hexokinase-2 expression promotes a pro-tumorigenic immune microenvironment by modulating CD8+/regulatory T-cell infiltration
Kim, S., Koh, J., Song, S. G., Yim, J., Kim, M., Keam, B., kim, Y. T., Kim, J., Chung, D. H., & Jeon, Y. K. (2022) · Figshare · doi:10.6084/m9.figshare.21455986
Additional file 1 of Bladder cancer-derived exosomal KRT6B promotes invasion and metastasis by inducing EMT and regulating the immune microenvironment
Song, Q., Yu, H., Cheng, Y., Han, J., Li, K., Zhuang, J., Lv, Q., Yang, X., & Yang, H. (2022) · Figshare · doi:10.6084/m9.figshare.20252759
Additional file 8 of Identification of two novel lipid metabolism-related long non-coding RNAs (SNHG17 and LINC00837) as potential signatures for osteosarcoma prognosis and precise treatment
Tang, Z., Feng, H., Shu, L., Guo, M., Qi, B., Pu, L., Shi, H., Ren, J., & Li, C. (2023) · Figshare · doi:10.6084/m9.figshare.23207841
Additional file 6 of Bladder cancer-derived exosomal KRT6B promotes invasion and metastasis by inducing EMT and regulating the immune microenvironment
Song, Q., Yu, H., Cheng, Y., Han, J., Li, K., Zhuang, J., Lv, Q., Yang, X., & Yang, H. (2022) · Figshare · doi:10.6084/m9.figshare.20252774
Additional file 2 of Clinical significance and oncogenic function of NR1H4 in clear cell renal cell carcinoma
Huang, S., Hou, Y., Hu, M., Hu, J., & Liu, X. (2022) · Figshare · doi:10.6084/m9.figshare.21171512
Additional file 2 of SLC27A2 mediates FAO in colorectal cancer through nongenic crosstalk regulation of the PPARs pathway
Shang, K., Ma, N., 车, 娟., Li, H., Hu, J., SUN, H., & Bangwei, C. (2024) · Figshare · doi:10.6084/m9.figshare.26581697
Additional file 7 of Bladder cancer-derived exosomal KRT6B promotes invasion and metastasis by inducing EMT and regulating the immune microenvironment
Song, Q., Yu, H., Cheng, Y., Han, J., Li, K., Zhuang, J., Lv, Q., Yang, X., & Yang, H. (2022) · Figshare · doi:10.6084/m9.figshare.20252777
Additional file 2 of High tumor hexokinase-2 expression promotes a pro-tumorigenic immune microenvironment by modulating CD8+/regulatory T-cell infiltration
Kim, S., Koh, J., Song, S. G., Yim, J., Kim, M., Keam, B., Kim, Y. T., Kim, J., Chung, D. H., & Jeon, Y. K. (2022) · Figshare · doi:10.6084/m9.figshare.21455983
Additional file 1 of Identification of molecular subtypes and a novel prognostic model of diffuse large B-cell lymphoma based on a metabolism-associated gene signature
He, J., Chen, Z., Xue, Q., Sun, P., Wang, Y., Zhu, C., & Shi, W. (2022) · Figshare · doi:10.6084/m9.figshare.19654684
Additional file 7 of Identification of molecular subtypes and a novel prognostic model of diffuse large B-cell lymphoma based on a metabolism-associated gene signature
He, J., Chen, Z., Xue, Q., Sun, P., Wang, Y., Zhu, C., & Shi, W. (2022) · Figshare · doi:10.6084/m9.figshare.19654705
Additional file 4 of High tumor hexokinase-2 expression promotes a pro-tumorigenic immune microenvironment by modulating CD8+/regulatory T-cell infiltration
Kim, S., Koh, J., Song, S. G., Yim, J., Kim, M., Keam, B., Kim, Y. T., Kim, J., Chung, D. H., & Jeon, Y. K. (2022) · Figshare · doi:10.6084/m9.figshare.21455989
Editorial: Immune-checkpoint inhibitors and immunometabolic reprogramming in cancer immunotherapy
Kumar, V., & Falco, V. D. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1760910
Melanoma causes phenotypic modulations and metabolic switches of iNKT cells influencing clinical outcomes
Degeorges, E., Mouret, S., Girard, P., Niveau, C., Cettour-Cave, M., Cuevas, E. S., de Fraipont, F., Charles, J., Saas, P., & Aspord, C. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1703754
Lactate-Driven Heterogeneity of Immune Checkpoint Expression in Breast and Lung Cancer Cell LinesPreprint
San-Millán, I., Martinez, J. L., Pickard, S. L., Hirsch, F. R., Rivard, C. J., & Brooks, G. E. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.11.698903
CD300ld blockade overcomes PMN-MDSC-mediated vaccine resistance in advanced tumors
Wang, X., Xue, S., Li, Y., Yang, M., Yu, H., Wang, M., Li, S., Lu, Z., & Luo, M. (2026) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-013336
Engineered Bacterial Biosynthesis of a Cysteine-Rich SPRR2A Fusion Protein with Dual Antibacterial and Anticancer Efficacy
He, P., Liu, H., Yuan, J., Gao, H., Li, B.-C., Stauber, R. H., Li, B., & Ding, G. (2026) · ACS Synthetic Biology · doi:10.1021/acssynbio.6c00021
Transportation Immune System
Zhang, J. (2026) · Urban sustainability · doi:10.1007/978-981-95-5393-8_9
Nanoplatform-mediated metabolic reprogramming to overcome resistance mechanisms in antitumor therapies
Lu, X.-X., Yang, J., & Gao, F. (2026) · Journal of Materials Chemistry B · doi:10.1039/d6tb00098c
Microbiota-driven immunometabolic regulation in colorectal cancer: Mechanisms and therapeutic opportunities
Luan, W.-Y., Zhang, S.-P., Xu, K.-Z., Shang, Y.-H., Hu, W., Sun, H., & Miao, Y. (2026) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v18.i3.115722
Intracellular oxygen monitoring and oxygen demand assessment using Ir(ppy)3-encapsulated polymeric micelles
Kitamura, N., Kajiwara, K., Yamamoto, S., Takano-Kasuya, M., Hiyama, K., Kita, H., & Gonda, K. (2026) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2026.118632
Recâblage métabolique des cellules dendritiques pour dynamiser l’immunité antitumorale
Aspord, C., Niveau, C., & Saas, P. (2026) · médecine/sciences · doi:10.1051/medsci/2026032
Impact de la perte du transporteur mitochondrial UCP2 sur la physiologie de l'intestin et l'immunité favorisant la tumorigenèse colorectale
Luby, A. (2024) · theses.fr (ABES) · doi:10.70675/8759af0czcd7cz459az8396z5ab690fd4aa1
Identification of a fatty acid metabolism-related gene signature for prognostic prediction and immune microenvironment characterization in diffuse large B-cell lymphoma
Wang, S., Wang, F., Li, M., Gu, Z., & Gu, Z. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1798939
Integrated transcriptomic and metabolomic analyses reveal host–metabolite interactions underlying cloacal inflammation in laying Pekin ducks
Xu, Y., Cai, W., Yang, Q., Liu, Z., Sheng, X., Hou, S., & Hu, J. (2026) · Animal Bioscience · doi:10.5713/ab.260208
Gastric Cancer Heterogeneity-Driven Remodeling of the Tumor Immune Microenvironment: Integrated Advances from Molecular Subtyping to Emerging Immunotherapeutic Strategies
牛, 雨. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.1641590
Hypoxia-inducible factor in hepatocellular carcinoma: From pathogenesis to therapeutic potential
Chi, Z.-C. (2026) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v34.i3.207
Current advanced immunological tools and databases in tumor immunity
Ahmed, T., Alam, K. T., & Tisha, Z. T. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-41551-7.00019-9
Tumor glycosylation engages CD301b-mediated myeloid regulation in breast cancerPreprint
Ozdilek, A., Paschall, A. V., Nawaz, F. Z., Niyas, A. M. M., & Avci, F. Y. (2026) · Research Square · doi:10.21203/rs.3.rs-9347231/v1
A smart polymer-based nanoplatform potentiates cancer ferroptosis-immunotherapy via perturbing metabolic compensation
Li, Y., Zhang, M., Weng, X., Guo, Y., Zhao, G., Wang, Y., Wang, X. G., Zhang, J., Ma, R., Gong, X., et al. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115001
FDX1 as a predictive biomarker and therapeutic target for lymph node metastasis in gastric cancer
Zhang, T., Liu, J., Duan, P., Li, Z., Huang, Z., Zhao, Z., Cheng, Y., Liang, Z., Chen, J., Cai, M., et al. (2026) · Clinical and Experimental Medicine · doi:10.1007/s10238-026-02160-0
Tumor Microenvironment in Pancreato-biliary Cancers: Crosstalk, Complexity, and Therapeutic Opportunities
Parthiban, R., Bhavya, E., Gujjula, T. R., Vijayan, M. R., Nandakumar, K., Murugathirumal, A., & Valliappan, S. (2026) · Journal of Bio-X Research · doi:10.34133/jbioxresearch.0082
Cancer and Immune Cells: A Metabolic Battle in the Tumor Microenvironment
Pournezhad, S., Azar, R., & Taghizadeh‐Hesary, F. (2026) · Cancer treatment and research · doi:10.1007/978-3-032-21861-2_11
Small extracellular vesicles in tumor metabolism and immune escape: biomarkers and therapeutic opportunities
Ghadiri, N., Aru, B., Ganjalikhani-Hakemi, A., Ganjalikhani-Hakemi, M., Ganjalikhani-Hakemi, M., & Hosseini, R. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12012-5
The competition of amino acid among tumors, tumor-associated macrophages and T cells based on metabolic reprogramming
Xianyu, C., Song, Y., Zhao, C., Min, Q., Wang, Z., Zhang, M., & Zhang, B. (2026) · iScience · doi:10.1016/j.isci.2026.116253
VSIG4 suppresses antitumor T cell immunity via the SLC3A2-dependent metabolic–ionic checkpoint
Huang, G., He, R., Wang, W., Wang, H., Li, Y., Zeng, B., Shu, P., Pan, T. S., Yi, M., Feng, L., et al. (2026) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-013562
C-Reactive Protein–Albumin–Lymphocyte Index and the Modified Glasgow Prognostic Score as Predictors of Early Mortality After Palliative Percutaneous Transhepatic Biliary Drainage in Malignant Biliary Obstruction
Sevim, H. A., Yucel, K. B., Uyar, G. C., & Şahinli, H. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15124608
Structural basis of ligand selectivity in FAD/NAD(P)H‐dependent dehydrogenases: insights from trypanothione reductase and type II NADH dehydrogenase
Perrone, G. C. M., Spadone, S., Francavilla, A. L., Morselli, S., Todisco, S., Ortalli, M., Mendoza‐Roldan, J. A., Scaglione, V., Sgobba, M. N., Guerra, L., et al. (2026) · Protein Science · doi:10.1002/pro.70664
Limitations of using citrulline levels as a marker of gastrointestinal function in patients with chronic intestinal failure
Goral, K., & Matras, P. (2026) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2026.103421
An in vivo platform to jointly monitor cellular and metabolic responses to chemotherapyPreprint
Pister, V. I., Tatárová, Z., Park, N. R., Gaidhani, G., Jakubík, J., Heiser, L. M., Blum, J. L. E., Palmiotti, A., Maloney, E., Fraenkel, E., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.25.734296
Single-cell and spatial omics in non-small cell lung cancer: dissecting metabolic reprogramming and tumor-immune ecosystems for precision pharmacology
Lian, Z., Wu, X. J., Zhou, Y., Tang, P., & Ge, H. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1865367
Feasibility Study of Intratumoral NRF2 Expression as a Predictive Biomarker for the Effectiveness of Immunotherapy in Patients with Non-Small Cell Lung Cancer Treated with PD-1 Inhibitor
Jin, Y., Inoue, Y., Shimada, H., Hara, T., Yamashita, S., Yamamoto, M., & Matsubara, O. (2026) · Cancers · doi:10.3390/cancers18142202
Tumour-Associated Neutrophils in Colorectal Cancer: a Systematic Review, Meta-analysis, and Comprehensive Literature Review
Abrahão, A. B. K., Felismino, T. C., & Kerr, D. (2026) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-026-01517-8
Effects of Three Dried Citrus Peels as Feed Additives on Growth Performance and Intestinal Microbiota of Oreochromis niloticus
Yang, Y., Wang, Z., Hao, Y., Yang, C., Xie, S., Li, X., Li, N., Jiang, X., Zhang, W., & Liang, S. (2026) · Aquaculture Nutrition · doi:10.1155/anu/5579376
Integrative single-cell and spatial transcriptomic analysis reveals a lactate-driven crosstalk between NFATc4⁺ tumor cells and SPP1⁺ macrophages in glioblastoma
Wang, R., Wu, W., Wu, X.-D., Yuan, Y., Zhang, Z., Chen, J. L., Xie, Y. U. Q. I. A. O., Zhang, L., Yu, X. Y., Zhang, H., et al. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08555-7
Metabolomics and Malignant Tumors of the Digestive Tract
Ji, J., Xing, X., Huangfu, L., Chen, L., & Li, C. (2026) · Springer eBooks · doi:10.1007/978-981-95-9567-9_4
Metabolic Reprogramming in Oral Cancer: A Narrative Review of Therapeutic Perspectives with Emphasis on Dichloroacetate
Senlle, S., Nicole, C., Silva, P. M. A., Queirós, O., & Cunha, A. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48070724
Transcriptomic, epigenetic, and immune-infiltration analyses to identify molecular drivers associated with clinical outcomes in ovarian cancerPreprint
Ajjarapu, S. M., Prasad, B. R., Singh, D. B., & Tiwari, A. (2026) · Research Square · doi:10.21203/rs.3.rs-10351877/v1
CD8+ T-cell effector programming is epigenetically regulated by DUSP2 through BAF complex-driven chromatin remodeling.
Dellacecca, E., Hirdler, J. B., Barham, W., Li, Y., Gicobi, J., Yan, Y., & Dong, H.-D. (2026) · Journal of Immunology · doi:10.1093/jimmun/vkag202
Multiomic immune microenvironment signatures associated with response and resistance to immune checkpoint blockade across solid tumours
Ayobami, F. S., Udo, I. A., Odega, K., Omisakin, I. A., OLATUNDE, O. J., JIMMY, I. O., Afamefuna Cyril, E. G. B. O., Ajani, O. F., Osuji, B.-M. C., ONOKEVBAGBE, I. G., et al. (2026) · Discover Oncology · doi:10.1007/s12672-026-05652-3
Monitoring Early Efficacy of the Checkpoint Immunotherapy Based on Fluorescence Lifetime Imaging Microscopy of the Patient-Derived Lymphocyte Subsets
Yuzhakova, D. V., Kononova, A. I., Izosimova, A. V., Sazhina, M. M., Shchechkin, I. D., Mozherov, A. M., Bureev, P. A., Kuzmin, D. A., Gavrina, A. I., Shumskaya, I. S., et al. (2026) · Biochemistry (Moscow) · doi:10.1134/s0006297926601206
Synthesis and Antitumor Mechanism of Emodin-Derived Transition Metal Complexes
Pan, Y., Rui, Y., 邹碧群, Jing, X., He, R., Liang, J., & Li, F. (2026) · Molecules · doi:10.3390/molecules31152682
Metabolic Profiling of Circulating and Tumour‐Infiltrating T Cells Uncovers Bioenergetic Checkpoints Linked With Immune and Clinical Skewing in Melanoma Patients
Brouque, H., Madhy, K., Mouret, S., Henry, S., Niveau, C., Cettour-Cave, M., Pelosse, M., de Fraipont, F., Charles, J., Turtoï, A., et al. (2026) · Immunology · doi:10.1111/imm.70185
PD-L1 intracellular domain-mimicked poly-metformin synergistically enhances macrophage antigen presentation for colorectal cancer oral immunotherapy
Sun, S., Fang, Y., Hao, H., Yu, J., Zhou, Y., Wen, S., Li, Y., Wang, T., Yu, M., & Wu, M. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124546
Targeting Immune Cell Metabolism for Cancer Immunotherapy
Jiang, Y., Wu, Y.-L., & Ying, T.-L. (2026) · Cancer Biome and Targeted Therapy · doi:10.66505/cbtt.v1i3.48
Coupling redox regulation with Cancer immunotherapy: The challenge of polyphenol Nanocarriers
Curcio, M., Saletta, F., Scorzafave, L., Fiore, M., Nicoletta, F. P., Iemma, F., Vittorio, O., & Cirillo, G. (2026) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2026.115956
A Machine Learning-Driven Four-Gene Signature Integrating Ferroptosis, Cuproptosis, and Immune Pathways for Diagnosis, Prognosis, and Therapeutic Guidance in Lung Adenocarcinoma
Al-Sabri, A. E., Al-Malahi, N. M., Talib, M., Umaid, M., Raja, R. K., Gul, R., & ALKHURIJI, A. F. (2026) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-026-10963-7
A lactate–α-ketoglutarate metabolic circuit in tumor-infiltrating regulatory T cells accelerates tumor progression by inducing NK cell senescence
Shi, T., Ding, Y., Chen, Y., Tan, X., Qu, F., Xu, D., Liu, X., Li, Y., Liu, Y., Zhang, X., et al. (2026) · Nature Cancer · doi:10.1038/s43018-026-01210-6
Oncometabolites in Cancer Metabolism: Mechanistic Insights and Biomarker Potential‐ A Narrative Review
Khatun, M. M., Sarker, M. A., Podder, M. K., Biswas, M. S., Hasan, M. M., Tamannaa, Z., Hossain, M. N., Badhon, R. S., & Akter, M. A. (2026) · Health Science Reports · doi:10.1002/hsr2.73070
Lactate as a Master Regulator of Immune Suppression: From Metabolic Waste to Epigenetic Checkpoint in Colorectal Cancer
Chen, B., Gao, S., Chen, X., Shi, Q., Mingli, S., & Han, J. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27167495
Molecular clusters and precision medicine in pheochromocytomas and paragangliomas
Almeida, M. Q., Dahia, P. L. M., & Robledo, M. (2026) · Endocrine Related Cancer · doi:10.1530/erc-26-0258
Metabolism in Tumor: Mechanisms and Therapeutic Perspectives
Cheng, J.-C., Hu, Y.-X., Huang, X.-C., Jiang, S., Wang, J.-L., Zhao, Y., & Chen, S. (2026) · MedComm · doi:10.1002/mco2.70928
Inflammation and tumor microenvironment
Xia, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-36649-9.00001-3
Mechanisms of Resistance to Immune Checkpoint Inhibitors and Therapeutic Strategies to Overcome Them: An Integrative Review
Lotfi, E., & Golab, F. (2026) · Cancer Investigation · doi:10.1080/07357907.2026.2725033 · Cited by 2
Immunotherapy and inflammation management
Xie, Y., Kong, M., & Yu, J. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-36649-9.00006-2
Targeting metabolic reprogramming in cancer: Past, present, and future
Kumari, N., Shukla, S. K., & Thakur, R. (2026) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2026.109109
Advances in the role of mitochondrial homeostasis in hepatocellular carcinoma initiation and progression: Mechanisms and therapeutic opportunities
Xu, J., Meng, X., Gong, M., Sun, E., Sun, J., Hamdy, H., Shen, J., & Li, H. (2026) · Mitochondrial Communications · doi:10.1016/j.mitoco.2026.07.002
Mitochondrial Fitness as a Functional Immune Checkpoint in Cancer: Metabolic Plasticity, Tumor Evolution, and Immunotherapy
Morabito, F., Martino, E. A., Bruzzese, A., Amodio, N., Vigna, E., & Gentile, M. (2026) · Cancers · doi:10.3390/cancers18172818
Dynamic Immune Responsiveness in Breast Cancer: Tumor Microenvironment Plasticity, Therapeutic Timing, and Clinical Translation
Udden, S. N., Obaid, M., Pop, L. M., & Hannan, R. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27198854
Mechanism and clinical relevance of metabolic-immune cross-talk in pancreatic tumor microenvironment
Malik, J. A., Jatavath, M., Fishel, M. L., Bhatia, R., & Gautam, S. K. (2026) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2026.08.005
Metabolic licensing and restriction of innate immunity in the tumor microenvironment
Shin, J. M., Choi, H. Y., Kim, J., & Lim, S. A. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1935435
Metabolite-driven dysfunction of intratumoral tertiary lymphoid structures: single-cell and spatial omics perspectives on cancer immune escape
Wang, Y., Li, Y., Wei, S., & Ding, S. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1889313
Heterogeneity in cancer: molecular mechanisms and therapeutic strategies
He, Y., Niu, L., Ren, Y.-M., Yuan, G.-Q., Pan, Y.-W., & Jin, W. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-03064-x
Rapid Single-Cell N-glycosylation Profiling of Circulating Human Immune Cells by Mass Spectrometry Imaging
Young, L. E. A., Hill, L. E., Dressman, J. W., Kittrell, C. G., Bejar, K., Sells, B. E., Mehta, A. S., Leach, R. J., DeNardo, D. G., & Drake, R. R. (2026) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.6c00321
Natural killer cell-based therapy for hepatocellular carcinoma (HCC): A literature review
Widowati, W., Wargasetia, T. L., Sadri, B., Nainggolan, I. M., Azis, R., Rifana, S. D., Rismani, E., & Vosough, M. (2026) · Medical Oncology · doi:10.1007/s12032-026-03393-5
MTHFD1L-associated branched-chain amino acid degradation transcriptional signature represents a conserved metabolic program in Epstein-Barr virus-associated malignancies
Zhou, J., Hao, H., Zhang, W., Mao, L., Zhao, X., & Zhu, J. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1955009
Self-assembled ferric–shikonin–quercetin (FSQ) nanoparticles co-delivering R848 enable lactate reduction, ICD induction, and immune modulation in vitro
Peng, X., Chen, Q.-W., Chang, J., Liu, Y., Liu, Y., & Liu, Z. (2026) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2026.116229
Metabolic reprogramming and plasticity in breast Cancer: Mechanisms driving tumor progression, metastasis, and therapeutic resistance
Yuan, J., Zhang, H., Huang, J., Wang, B., Wang, M., & Yang, L. (2026) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2026.189733
Portal Vein Tumor Thrombus in Hepatocellular Carcinoma: An Immune Sanctuary Driving Immune Exclusion and Therapeutic Resistance
Li, X., Cheng, Q., Zhu, J., Yuan, Z., Mu, S., Zhou, T., & Gao, J. (2026) · Liver Cancer · doi:10.1159/lic/admag011
Cancer competition for vitamin B2 creates metabolic checkpoint for T cell ferroptosis
Chen, H., Li, C., Ke, Y., Wu, Z., Ou, Z., Huang, N., Lin, Z., Gao, H., Xu, X., Lu, L., et al. (2026) · Cell · doi:10.1016/j.cell.2026.09.020
The “Selfish Cell”: The Central Role of Metabolism in Relaying Environmental Stimuli and Controlling Cellular Function
Matteo, S. D., & Gnocchi, D. (2026) · Biology · doi:10.3390/biology15191790
Metformin-loaded multi-enzymatic metal-organic framework nanozyme mediates metabolic reprogramming via multiple energy blockades to boost tumor immunotherapy
He, L., Li, T., 王丽晔, Wang, W., Chang, L., Shen, Z., Zhao, L., Yin, X., & Zeng, L. (2026) · Acta Biomaterialia · doi:10.1016/j.actbio.2026.10.014
Shugan-Liangxue Prescription Inhibits Immune Escape Against Breast Cancer by Regulating Tryptophan Metabolism
杨有占, Liu, J., Shi, R., Li, X., Li, S., Lin, Y., 王月琦, Cai, D., Cheng, Z., & Xin, Z. (2026) · Integrative Cancer Therapies · doi:10.1177/15347354261494127
Engineered biomimetic nanovaccine regulates macrophage-B cell metabolism to overcome immune resistance and induce tertiary lymphoid structure formation in solid tumors
Wang, M., Chen, J., 吴中华, Wang, Z., Zhong, Z., & Zhong, Y. (2026) · Materials Today Advances · doi:10.1016/j.mtadv.2026.101014
Stemness overcomes IFNγ-induced antitumour exhaustion in human macrophagesPreprint
Nitsche, J., Busch, C. J., Subburayalu, J., Favret, J., Swiersy, A., Hertrich, M., Rost, F., Ivan, D., Benjamin, J., Franco, M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.06.756629
Targeting myeloid cell plasticity and metabolic reprogramming to alleviate T cell dysfunction and exhaustion-associated states and enhance immune checkpoint blockade therapy
Wang, M., Chen, J., 吴中华, Wang, Z., Zhong, Z., & Zhong, Y. (2026) · Biomarker Research · doi:10.1186/s40364-026-01011-0
Helicobacter pylori infection reduces cancer immunotherapy efficacy through hepatic urea cycle activation and creatine depletion
Peter, B., Ongaro, M., Mager, L. F., Rochat, K., Gaillard, C., Breuillard, N., Poms, M., Serex, C., Godat, S., Braissant, O., et al. (2026) · Gut Science · doi:10.1136/gutsci-2026-000039
Cancer Cell Metabolic Reprogramming: Dietary, Pharmacological Strategies and Clinical Perspectives
Xydas, N., Panagiotou, Ε., Kassos, V., Gkirmpa, A. M., Kassou, P., Voyiatzis, I., Prenti, P., Manias, G., Vakrakou, A. G., & Anagnostopoulos, A. K. (2026) · Cancers · doi:10.3390/cancers18203372
Neutrophil–epithelial niches arrest B-cell maturation in dysfunctional tertiary lymphoid structures of gastric cancer neoadjuvant immunochemotherapy
Wei, C., Fu, Q., Wei, H., Zhai, H., Dong, S., Ma, X., Bie, L., Ma, Y., Wang, Y., Xia, Q., et al. (2026) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2026-016301
Revisiting Ehrlich carcinoma in the era of precision oncology: bridging classical models with modern systems biology
Manjunath, V., Nayak, R., Bhujanga, A. K., Ramesh, A. M., & Santhekadur, P. K. (2026) · Medical Oncology · doi:10.1007/s12032-026-03452-x
Inorganic nanomaterial-based tumor vaccines
Fan, Y., Zhang, J., Wang, Z., Ren, Y., Li, Z., & Luo, D. (2026) · Progress in Natural Science Materials International · doi:10.1016/j.pnsc.2026.08.026
Advanced Nanomedicines for Cancer Metabolic Therapy
Duan, Q., Tian, C., Cheng, X., Wang, L., Huo, M., & Shi, J. (2026) · Advanced Materials · doi:10.1002/adma.75365
Astragaloside IV and tumor microenvironmental barriers: immune mechanisms, evidence hierarchy, and implications for checkpoint blockade
Wang, Y., Liu, M., & Zhong, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1991297
Mitochondrial Fitness in Anti-Tumor T Cells: From Activation to Exhaustion and Memory Formation
Lee, D.-K., & Seo, J. H. (2026) · Biomolecules · doi:10.3390/biom16111539
X-ray-Triggered Nanoadjuvant Enabling Spatiotemporal Immunometabolic Modulation for Pyroptosis-Enhanced Radiotherapy
Liu, W., Chen, Y., Xiao, Y., Gao, J., Hu, S., Chen, L., Song, J., & Yang, H. (2026) · Nano Letters · doi:10.1021/acs.nanolett.6c04189
BindingDB Entry 50022928: Novel PD-L1/VISTA Dual Inhibitor as Potential Immunotherapy Agents.
BindingDB (2026) · UC San Diego · doi:10.7270/q2qz2gt3
Integrative bioinformatics and experimental validation of the prognostic and functional relevance of XDH and ITPA in non-small cell lung cancer
Zhang, W., Song, J., Zhu, H., Wang, Y., Wang, H., & Li, X. (2026) · Functional & Integrative Genomics · doi:10.1007/s10142-026-02100-x

Authors: Leone, R. D., & Powell, J. D.
Affiliations: Johns Hopkins University (US)
Corresponding author: Powell, Jonathan D.
ORCID: Leone, Robert D.
Powell, Jonathan D.
Venue: Nature Reviews Cancer
Publisher: Springer Science and Business Media LLC
Published: 2020-07-06
Volume: 20
Issue: 9
Pages: 516-531
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/s41568-020-0273-y
PMC: PMC8041116
OpenAlex: W3040651070
Semantic Scholar: 9e54633c23933564226222b58eee14bffccca97c
Cited by: 877
References: 228
Citations by year: 2026: 137 · 2025: 168 · 2024: 141 · 2023: 135 · 2022: 185 · 2021: 98 · 2020: 12
FWCI: 11.48
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Cancer Institute (R01CA229451, R01CA226765)
National Institute of Allergy and Infectious Diseases (R01AI077610)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
Keywords: immune cell metabolism, cancer metabolism, tumor microenvironment, tumor acidosis, tumor hypoxia, nutrient depletion, adaptive immunity, innate immunity, metabolic heterogeneity, metabolic plasticity, metabolic vulnerability, immunotherapy, antitumor immunity
MeSH terms: Animals, Humans, Immune System, Immunotherapy, Neoplasms, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Metabolism of immune cells in cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks